Priapism associated with oxcarbazepine, aripiprazole, and lithium.
Negin
Brett
B
Murphy
Tanya K
TK
D000293:Adolescent; D000342:Affective Symptoms / Q000175:diagnosis / Q000188:drug therapy; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects*; D018692:Antimanic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000068180:Aripiprazole; D001714:Bipolar Disorder / Q000175:diagnosis / Q000188:drug therapy*; D002220:Carbamazepine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D002648:Child; D002659:Child Development Disorders, Pervasive / Q000175:diagnosis / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D016651:Lithium Carbonate / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D000078330:Oxcarbazepine; D010410:Penile Erection / Q000187:drug effects; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects*; D011317:Priapism / Q000139:chemically induced*; D015363:Quinolones / Q000008:administration & dosage / Q000009:adverse effects*
D000927:Anticonvulsants; D018692:Antimanic Agents; D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D016651:Lithium Carbonate; D002220:Carbamazepine; D000068180:Aripiprazole; D000078330:Oxcarbazepine